© The Author 2006. Published by Oxford University Press.
BRIEF COMMUNICATION |
Cholesterol-Lowering Drugs and Colorectal Cancer Incidence in a Large United States Cohort
Affiliation of authors: Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA
Correspondence to: Eric J. Jacobs, PhD, Epidemiology and Surveillance Research, American Cancer Society, National Home Office, 1599 Clifton Road NE, Atlanta, GA 30329 (e-mail: Eric.Jacobs{at}cancer.org).
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, commonly known as statins, account for most cholesterol-lowering drug use in the United States. A recent large case-control study reported that use of statins for more than 5 years was associated with a 47% reduction in risk of colorectal cancer. No other large studies have examined this association. We examined the association between use of cholesterol-lowering drugs and colorectal cancer incidence among 132 136 men and women in the Cancer Prevention Study II Nutrition Cohort. We identified 815 incident cases of colorectal cancer among study participants during follow-up from the date of completion of a study questionnaire in 1997 through August 31, 2001. Current use of cholesterol-lowering drugs was not associated with colorectal cancer incidence (multivariable adjusted rate ratio [RR] = 1.03, 95% confidence interval [CI] = 0.85 to 1.26). Current use of cholesterol-lowering drugs for 5 years or more was also not associated with colorectal cancer incidence (multivariable adjusted RR = 1.09, 95% CI = 0.83 to 1.43). Our results do not support the hypothesis that statin use strongly reduces risk of colorectal cancer. However, we cannot rule out a small reduction in risk or an effect associated with only specific types or doses of statins.
CiteULike 
Connotea 
Del.icio.us What's this?
Find additional patient-related information at:
Editorial about this Article
- Stats on Statins: Anything but Static
- John McLaughlin
J Natl Cancer Inst 2006 98: 4-5.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  T. Toyoda, T. Tsukamoto, S. Takasu, N. Hirano, H. Ban, L. Shi, T. Kumagai, T. Tanaka, and M. Tatematsu Pitavastatin Fails to Lower Serum Lipid Levels or Inhibit Gastric Carcinogenesis in Helicobacter pylori-Infected Rodent Models Cancer Prevention Research, August 1, 2009; 2(8): 751 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Boudreau, E. Koehler, S. J. Rulyak, S. Haneuse, R. Harrison, and M. T. Mandelson Cardiovascular Medication Use and Risk for Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3076 - 3080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Farwell, R. E. Scranton, E. V. Lawler, R. A. Lew, M. T. Brophy, L. D. Fiore, and J. M. Gaziano The Association Between Statins and Cancer Incidence in a Veterans Population J Natl Cancer Inst, January 16, 2008; 100(2): 134 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-L. Chen, I-H. Liu, S. J. Fliesler, X. Han, S. S. Huang, and J. S. Huang Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis J. Cell Sci., October 15, 2007; 120(20): 3509 - 3521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Shachaf, O. D. Perez, S. Youssef, A. C. Fan, S. Elchuri, M. J. Goldstein, A. E. Shirer, O. Sharpe, J. Chen, D. J. Mitchell, et al. Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis Blood, October 1, 2007; 110(7): 2674 - 2684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bonovas, K. Filioussi, C. S. Flordellis, and N. M. Sitaras Statins and the Risk of Colorectal Cancer: A Meta-Analysis of 18 Studies Involving More Than 1.5 Million Patients J. Clin. Oncol., August 10, 2007; 25(23): 3462 - 3468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Neugut, B. Lebwohl, and D. L. Hershman Cancer Chemoprevention: How Do We Know What Works? J. Clin. Oncol., April 20, 2007; 25(12): 1461 - 1462. [Full Text] [PDF]
|
|
|
|
|
|
P. F. Coogan, J. Smith, and L. Rosenberg Statin Use and Risk of Colorectal Cancer J Natl Cancer Inst, January 3, 2007; 99(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Setoguchi, R. J. Glynn, J. Avorn, H. Mogun, and S. Schneeweiss Statins and the Risk of Lung, Breast, and Colorectal Cancer in the Elderly Circulation, January 2, 2007; 115(1): 27 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Platz, M. F. Leitzmann, K. Visvanathan, E. B. Rimm, M. J. Stampfer, W. C. Willett, and E. Giovannucci Statin Drugs and Risk of Advanced Prostate Cancer J Natl Cancer Inst, December 20, 2006; 98(24): 1819 - 1825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Landgren, Y. Zhang, S. H. Zahm, P. Inskip, T. Zheng, and D. Baris Risk of Multiple Myeloma following Medication Use and Medical Conditions: A Case-Control Study in Connecticut Women Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2342 - 2347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kim Statin and Cancer Risks: From Tasseomancy of Epidemiologic Studies to Meta-Analyses J. Clin. Oncol., October 20, 2006; 24(30): 4796 - 4797. [Full Text] [PDF]
|
|
|
|
 |
|
 U. Sivaprasad, T. Abbas, and A. Dutta Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. Mol. Cancer Ther., September 1, 2006; 5(9): 2310 - 2316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Swamy, J. M.R. Patlolla, V. E. Steele, L. Kopelovich, B. S. Reddy, and C. V. Rao Chemoprevention of Familial Adenomatous Polyposis by Low Doses of Atorvastatin and Celecoxib Given Individually and in Combination to APCMin Mice. Cancer Res., July 15, 2006; 66(14): 7370 - 7377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 JournalScan Gut, July 1, 2006; 55(7): 1036 - 1036. [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Kelloff, S. M. Lippman, A. J. Dannenberg, C. C. Sigman, H. L. Pearce, B. J. Reid, E. Szabo, V. C. Jordan, M. R. Spitz, G. B. Mills, et al. Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer--A Plan to Move Forward Clin. Cancer Res., June 15, 2006; 12(12): 3661 - 3697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. McLaughlin Stats on Statins: Anything but Static J Natl Cancer Inst, January 4, 2006; 98(1): 4 - 5. [Full Text] [PDF]
|
|